Diet and bacteria combination limits cancer progression

 

Researchers from the University of Luxembourg have discovered a combination of dietary factors and gut bacteria that inhibits the progression of colorectal cancer. The findings, published in the open-access journal Cell Reports, could help exploit dietary regimens for therapeutic purposes to improve chemotherapy efficacy and reduce toxicity.

Link between diet and cancer progression

The diet of a person can have significant effects on the gut microbiome, i.e. the populations of microorganisms such as bacteria which live in the human gut. It is well recognised that dietary habits through complex metabolic interactions contribute to cancer prevention. More specifically, diets rich in fibre reduce the risk of developing specific cancers such as colorectal cancer (CRC). Although such diets are an effective means of cancer prevention, their possible roles in cancer progression and treatment remains poorly understood.

A team of scientists from the Luxembourg Centre for Systems Biomedicine (LCSB) and the Life Sciences Research Unit (LSRU) at the University of Luxembourg has found that a combination of prebiotics, such as dietary fibre, and probiotics, i.e. specific beneficial bacteria, reduces the expression of pro-carcinogenic and drug resistance genes. The combination leads to metabolic changes that affect the growth of cancer cells and may help treat diseases such as CRC.

Real-life interactions between dietary fibre, bacteria and human cells

In order to study diet-microbiome-host interactions, the biologists worked with HuMiX (“Human-Microbial X(cross)-talk”) a unique in vitro model of the gut (“gut-on-a-chip”) which allows the cultivation of human intestinal cells together with bacteria under representative conditions. In this study, they investigated the effects of dietary regimens and a specific probiotic on CRC cells.

In contrast to individual fibre-rich or probiotic treatments, it was only the combination of fibre and probiotics that led to the observed beneficial effects. Together with their collaborators, the researchers integrated a computer-based metabolic model of the interactions between diet, host, and microbiome. They identified the effects of the combined treatment: the downregulation of genes associated with colorectal cancer and drug-resistance as well as the attenuation of self-renewal capacity of the cancer cells. Importantly, through careful molecular analyses, they also identified the cocktail of molecules produced by the combination, thereby providing a mechanistic basis for the observed beneficial effects.

“Currently, cancer patients are not provided with evidence-based personalised dietary interventions during chemotherapy treatment. Our results provide support for exploiting the food-microbiome interactions as a supportive therapeutic approach in anti-cancer therapy,” explains Dr. Kacy Greenhalgh, post-doc within the Eco-Systems Biology group at LCSB and the lead author of the study. “I hope that our results will reach patients and medical practitioners in their respective fields and that in the future more effort is put in including personalised dietary recommendations into cancer treatment plans.”

“This is especially the case in CRC, where the microbiome has increasingly gained importance over the last couple of years. A deeper understanding of the microbiome-host interaction could lead to new therapeutic strategies for CRC patients,” adds Dr. Elisabeth Letellier, principal investigator within the Molecular Disease Mechanisms Group at LSRU.

Collaborative and interdisciplinary approach

The research project was successfully carried out thanks to the collaborative effort of different groups at the University of Luxembourg. “Deciphering the complex host-diet-microbiome interactions and their effect on health and disease states requires the concerted effort of experts from different fields. The interdisciplinary approach was crucial for understanding the very complex molecular processes underlying the observed beneficial biological effects,” comments Associate Professor Paul Wilmes, head of the Eco-Systems Biology group at LCSB and senior author of the study.

The study was supported by the Luxembourg National Research Fund (FNR), the University of Luxembourg and the Personalised Medicine Consortium (PMC).

Caption: “Some of the researchers who carried out the study. From left to right: Audrey Frachet, Serge Haan, Elisabeth Letellier, Kacy Greenhalgh, Rashi Halder, Javier Ramiro-Garcia and Paul Wilmes.” Photo: © University of Luxembourg

Spotlight on Young Researchers: Kacy Greenhalgh

More highlights from this domain

  • All
  • Environmental & Earth Sciences
  • Humanities & Social Sciences
  • Information & Communication Technologies
  • Law, Economics & Finance
  • Life Sciences, Biology & Medicine
  • Materials, Physics & Engineering
  • Mathematics

Genetic forms of Parkinson’s disease: Stem cell research offers new insights

Fulbright: “An immense opportunity for exchange”

Novel molecule: New hope for the treatment of pain and depression

Spotlight on Young Researchers: Understanding how language manifests in the brain

FNR ATTRACT Fellows – the people behind the science: Anupam Sengupta

Turning ‘cold’ tumours ‘hot’: A novel approach to improved cancer immunotherapy

Spotlight on Young Researchers: Bella Tsachidou

Fighting autoimmunity and cancer: The nutritional key

Spotlight on Young Researchers: Nathasia Mudiwa Muwanigwa

FNR ATTRACT Fellows – the people behind the science: Johannes Meiser

Science has no gender: An ecohydrologist

Spotlight on Young Researchers: Noémie Catherine Engel

Opinion: Fake News about the Corona Virus and science in general

Luxembourg Parkinson’s Study: 1600 participants recruited!

FNR 20 years: An evening with science [fiction] in the House of Frankenstein

Toward a better understanding and diagnosis of neurodegeneration and brain tumours

From lab to spin-off: NIUM – nutrition as a therapeutic tool

Microbiome research: unlocking basic unknowns in human health

Spotlight on Young Researchers: Remko Nijzink

A modern and high quality environment for doctoral candidates in Luxembourg

The immune system: A delicate balance

Science meets rock’n’roll: what happens when a palaeontologist has a penchant for extreme metal music

10 years of Mr Science

Brain cancer: Cancer cells can change and adapt to their environment

Spotlight on Young Researchers: Understanding our immune system

Spotlight on Young Researchers: Carole Lara Veiga de Sousa

Spotlight on Young Researchers: Sebastian Scheer

Sharing insights to inspire the next generation

Spotlight on Young Researchers: Ernesto Gargiulo

Connecting fundamental research and clinical care

Triggered by fever: Enzyme mutation plays key role in novel fatal neurological disorder in children

Study reveals caesarean birth impacts child’s immune system

FNR ATTRACT Fellows – the people behind the science: Stan Schymanski

Shedding light on how colon cancer develops and progresses

From flood prediction to deep brain stimulation

“It was truly inspiring how new and older generations of scientists share ideas”

FNR ATTRACT Fellows – the people behind the science: Anne Grünewald

Spotlight on Young Researchers: Gilles Tossing

Luxembourg researchers discover significant lab kit contamination; team up with company to find solution

Spotlight on Young Researchers: Anna Monzel

AFR Postdoc: Biology of Ageing – A small protein with big potential

ATTRACT: Human metabolism as a computer model

Spotlight on Young Researchers: Antoun Al Absi

Spotlight on Young Researchers: Katharina Baum

FNR ATTRACT Fellows – the people behind the science: Paul Wilmes

Spotlight on Young Researchers: Amy Parrish

Spotlight on Young Researchers: Maria Pires Pacheco

FNR ATTRACT Fellows – the people behind the science: Ines Thiele

Research trends: Remote control from within – gut bacteria have an influence on neurological diseases

FNR ATTRACT Fellows – the people behind the science: Dirk Brenner

INTER: Luxembourg researcher in bilateral epigenetics project

Does Parkinson’s disease originate outside the brain? FNR ATTRACT Fellow leads study suggesting gut bacteria could play a role

Spotlight on Young Researchers: Xianqing Mao

Spotlight on Young Researchers: Lisa Hefele

ATTRACT: The female perspective

Spotlight on Young Researchers: Charles de Bourcy

Spotlight on Young Researchers: Kacy Greenhalgh

Spotlight on Young Researchers: Léon-Charles Tranchevent

Twisted: CORE project leads to innovative interdisciplinary conference

POC: Pocket-sized intestines – the HuMiX model enables intestinal flora to be investigated under real conditions

INTER Mobility: Lack of fibre makes intestinal bacteria aggressive

Spotlight on Young Researchers: Multiple nationalities, one goal

Spotlight on Young Researchers: Jo Hoeser

FNR ATTRACT Fellow in significant immunology discovery

Spotlight on Young Researchers: Pit Ullmann

Spotlight on Young Researchers: Nina Hentzen

Women in Science: Simone Niclou, oncologist

CORE Spotlight: How do eating disorders develop?

Luxembourg researchers develop computer models for hundreds of bacterial strains

Researchers’ Days: What it feels like to have Parkinson’s disease

Spotlight on Young Researchers: Cyrille Thinnes

How do malaria pathogens spread? Interview with biologist Philip Birget

NCER-PD: Meet Dany, the 100th Parkinson’s study control person

A Centre of Excellence in Research on Parkinson’s disease (NCER-PD)

Meeting with 65 Nobel Prize Winners in Lindau: Interview with Charles de Bourcy

RESCOM Spotlight: Largest medical congress in Luxembourg’s history

ATTRACT SPOTLIGHT: Exploring microbial ecosystems in humans

Interview with Gökhan Ertaylan: “Nobel Prize Winners are also just people”

This site uses cookies. By continuing to use this site, you agree to the use of cookies for analytics purposes. Find out more in our Privacy Statement